We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BV3 market cap is 1.61B. The company's latest EPS is DKK 12.6505 and P/E is 1.60.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 1.85B | 1.9B | 3.15B | 7.06B | 5.72B |
| Operating Income | 382.74M | -308.29M | -69.61M | 1.5B | 942.3M |
| Net Income | 277.52M | -464.78M | -347.38M | 1.48B | 987.98M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 8.76B | 12.09B | 12.39B | 14.35B | 14.41B |
| Total Liabilities | 3.86B | 4.71B | 5.24B | 4.01B | 3B |
| Total Equity | 4.89B | 7.37B | 7.15B | 10.34B | 11.41B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 571.91M | -358.5M | 220.05M | 1.12B | 1.95B |
| Investing | -1.91B | -2.88B | -877.41M | -945.56M | -1.87B |
| Financing | 1.33B | 3.54B | 635.82M | 735.83M | 55.78M |
| Market Cap | 1.61B |
| Price to Earnings Ratio | 1.60 |
| Price to Sales Ratio | 0.28 |
| Price to Cash Ratio | 0.97 |
| Price to Book Ratio | 0.14 |
| Dividend Yield | - |
| Shares Outstanding | 78.1M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 6.55k |
| 52 Week Change | 2.03% |
| 52 Week High | 42.77 |
| 52 Week Low | 17.185 |
| Spread (Intraday) | 0.2 (0.97%) |
| Company Name | Bavarian Nordic AS |
| Address |
hejreskovvej 10a kvistgaard DK-3490 |
| Website | https://www.bavarian-nordic.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
